| Cassandra Leach, | |
|
14409 Greenview Dr Ste 102, Laurel, MD 20708-4213 | |
| (301) 498-8100 | |
| (301) 498-0009 |
| Full Name | Cassandra Leach |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 14409 Greenview Dr Ste 102, Laurel, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205039062 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 05714 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cassandra Leach, 14409 Greenview Dr Ste 102, Laurel, MD 20708-4213 Ph: (301) 498-8100 | Cassandra Leach, 14409 Greenview Dr Ste 102, Laurel, MD 20708-4213 Ph: (301) 498-8100 |
News Archive
Genzyme, a Sanofi company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for approval of LEMTRADA (alemtuzumab) for the treatment of adult patients with relapsing remitting multiple sclerosis with active disease defined by clinical or imaging features.
Researchers studying yeast cells have identified a metabolic enzyme as a potential therapeutic target for treating Huntington's disease, a fatal inherited neurodegenerative disorder for which there is currently no effective treatment. The group, whose results appear in the May issue of Nature Genetics, includes researchers from the University of Washington School of Medicine in Seattle and the University of Maryland School of Medicine in Baltimore.
Neurons die en masse when the spinal cord is injured or when a person suffers a stroke. Researchers of the Max Delbrueck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, and of Aarhus University, Denmark, have unraveled the molecular mechanism which causes the death not only of damaged neurons, but also of healthy nerve cells.
Aegis Therapeutics LLC (Aegis) announced today that they have signed a License Agreement providing Roche access to Aegis' proprietary ProTek® stabilization technology. The ProTek® technology covers the use of specific excipients as stabilizers in certain manufacturing processes and formulations of protein-based therapeutics.
New research has revealed that exposure to common family problems during childhood and early adolescence affects brain development, which could lead to mental health issues in later life.
› Verified 2 days ago
Sylvia Toussaint, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr, Ste 102, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009 | |
Dr. Eldorna Samuel, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 10000 Running Sand Knl, Laurel, MD 20723 Phone: 301-641-7035 Fax: 301-850-7613 | |
Miss Heather Agostine Morgan, MS, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14502 Greenview Dr, Ste 406, Laurel, MD 20708 Phone: 866-566-5310 | |
Ayesha Iman Jackson, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009 | |
Mamta Sampemane, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Drive Ste 102, Laurel, MD 20708 Phone: 301-498-8100 | |
Sonya Mitchell, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr Ste 102, Laurel, MD 20708 Phone: 301-498-8100 | |
Deshaun Squires, MS, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14409 Greenview Dr, Laurel, MD 20708 Phone: 301-498-8100 Fax: 301-498-0009 |